Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

36,397.26ZAc
30 Apr 2015
Change (% chg)

200.00c (+0.56%)
Prev Close
36,000.00c
Open
36,300.00c
Day's High
37,158.00c
Day's Low
35,865.00c
Volume
3,028,525
Avg. Vol
1,438,521
52-wk High
44,868.00c
52-wk Low
27,151.00c

APNJ.J

Chart for APNJ.J

About

Aspen Pharmacare Holdings Limited is a South Africa-based pharmaceutical company. The Company through its subsidiaries manufactures branded and generic pharmaceutical products as well as infant milk nutritionals and consumer healthcare products in selected territories, operating primarily in the healthcare industry. The Company... (more)

Overall

Beta: 0.42
Market Cap(Mil.): R164,285.50
Shares Outstanding(Mil.): 456.35
Dividend: 188.00
Yield (%): 0.52

Financials

  APNJ.J Industry Sector
P/E (TTM): 29.67 39.17 40.23
EPS (TTM): 12.13 -- --
ROI: 8.38 15.86 15.26
ROE: 19.81 16.36 16.08
Search Stocks

GSK raises $853 million by halving stake in South African drugmaker

LONDON - GlaxoSmithKline has taken profits in Aspen Pharmacare by selling half its stake in the South African drugmaker for $853 million, following a long investment in the firm.

13 Mar 2015

BRIEF-GSK raises $853 mln via partial sale of Aspen Pharmacare shares

* GSK completes partial sale of Aspen Pharmacare Holdings Ltd shares - LSE announcement

13 Mar 2015

GSK to pocket $890 million by halving stake in South African drugmaker

LONDON - GlaxoSmithKline has decided to take profits in Aspen Pharmacare by halving its stake in the South African drugmaker, following a long investment in the firm.

12 Mar 2015

UPDATE 1-GSK to pocket $890 mln by halving stake in S.African drugmaker

LONDON, March 12 - GlaxoSmithKline has decided to take profits in Aspen Pharmacare by halving its stake in the South African drugmaker, following a long investment in the firm.

12 Mar 2015

GSK launches $890mln placement in Aspen Pharmacare - source

LONDON, March 12 - GlaxoSmithKline has launched a $890 million share sale in South African drug company Aspen Pharmacare, a source familiar with the matter said on Thursday.

12 Mar 2015

BRIEF-GSK to sell half of 12.4 pct stake in Aspen Pharmacare

* Intends to sell approximately half of its 12.4 pct stake in Aspen Pharmacare Holdings Ltd

12 Mar 2015

South Africa's Aspen first-half earnings up 22 percent as acquisitions kick-in

JOHANNESBURG - Africa's biggest generic drugmaker Aspen Pharmacare Holdings Ltd reported a 22 percent increase in half-year profit on Thursday as contributions from recent acquisitions offset the impact of unfavorable currency moves.

05 Mar 2015

BRIEF-Aspen Pharmacare sees HEPS up 25-30 pct for 6 months to Dec

* Sees headline earnings per share of 25% to 30% 530.2 to 551.5 cents for 6 months to Dec Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

26 Feb 2015

BRIEF-Aspen Pharmacare buys rights to Novartis anti-coagulant Mono-Embolex

* Acquisition of rights to an anti-coagulant product from Novartis

23 Jan 2015

Aspen, Cipla win share of $860 million South Africa AIDS drug tender

JOHANNESBURG - South Africa will spend 10 billion rand ($860 million) between 2015 and 2017 on life-prolonging HIV/AIDS treatment drugs, health authorities said on Wednesday, as studies show the prevalence of the virus is rising.

24 Dec 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$10.00
Provider: Sadif Analytics Prime
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks